February 10, 2025
Tag: Joshua Zeidner
December 5, 2024
UNC researchers presenting research advances at American Society of Hematology annual meeting
Nearly two dozen UNC faculty members and trainees will present research and participate in scientific symposia and educational sessions at the ASH Annual Meeting.
November 13, 2024
EMJ Podcast: Insights For Healthcare Professionals: Hema Now: Episode 4: Navigating Acute Myeloid Leukaemia
September 30, 2024
New treatments offer promise to people with acute myeloid leukemia
Joshua Zeidner, MD, a hematologist/oncologist specializing in the management of acute leukemia, explains some of the advances in the treatment of acute myeloid leukemia (AML).
December 9, 2022
UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
September 22, 2022
Accurate assessment of heart rhythm can optimize chemotherapy use
Using the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-saving chemotherapy, according to research findings from UNC Lineberger scientists.
April 12, 2022
Couple unified through cancer, caregiver struggles
When a significant other is diagnosed with cancer, it can be just as hard on the loved one as it is on the patient. However, Stephen and Jackie Alston found themselves experiencing both roles when they were each diagnosed with cancer years apart.
September 13, 2021
GEN: Immunotherapy Post Chemotherapy Shows Positive Results in Acute Myeloid Leukemia
September 10, 2021
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.